Biotech Stocks in Motion – Amgen, Merrimack Pharma, NPS Pharma, BioMarin Pharma, and Regeneron Pharma

LONDON, November 24, 2014 /PRNewswire/ –Investor-Edge has initiated coverage on the following equities: Amgen Inc. (NASDAQ: AMGN), Merrimack Pharmaceuticals Inc. (NASDAQ: MACK), NPS Pharmaceuticals Inc. (NASDAQ: NPSP), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN). Free research on these five companies can be accessed at: On Friday, November 21, 2014, the NASDAQ Composite ended at 4,712.97, […]